This research rejects any association between increased risk for ADHD and changes in children's microbiota related to cesarean delivery or antibiotic use.
Improving Medication Adherence in ADHD Lowers Risk for Oppositional Defiant Disorder, Conduct Disorder in AdulthoodSeptember 21, 2018
Researchers found that children who were compliant with drug therapy had a significantly lower risk for oppositional defiant disorder or conduct disorder than those who were noncompliant.
Clinicians may find these data useful in considering the mediating effects of family function and psychiatric comorbidities among patients with ADHD.
This increase may be the result of expanded continuing medical education regarding ADHD that has raised physician awareness, as well as modifications in diagnostic criteria.
Guidelines on which ADHD medications should be preferred across different age groups are unclear, and the safety and benefits of these medications remain controversial.
The authors argue that, given the findings of this study, the awareness of the detrimental effects of both smoking and depression upon children should be raised among parents.
From 1997-1998 to 2015-2016, there was an increase in the prevalence of ADHD among children.
The FDA stated that the dasotraline NDA cannot be approved in its current form and is requiring additional data to further assess the efficacy and tolerability of the drug.
Compared with controls, those with subthreshold ADHD experienced greater impairments in social functioning and had higher rates of requiring extra help in school.
Methylphenidate should be considered as a first choice for the treatment of ADHD in children and adolescents.
In this prospective cohort trial, teens with significant ADHD symptoms were slightly more likely to be associated with a higher frequency of digital media use.
The 7 treatments included in the study were amphetamines (including lisdexamfetamine), atomoxetine, bupropion, clonidine, guanfacine, methylphenidate, and modafinil.
Jornay PM utilizes the proprietary Delexis drug delivery platform which consists of 2 functional film coatings: the first layer delays the initial drug release for up to 10 hours and the second layer helps control the release rate of the active ingredient throughout the day.
These results indicate an association between adolescent engagement in digital media activities and subsequent ADHD symptoms.
There is a modest, but statistically significant, association between higher frequency of digital media use and subsequent symptoms of ADHD among adolescents.
These findings illustrate potential gains of reducing the number of preterm births and the importance of providing custom support to children born preterm to prevent neurodevelopmental problems.
Nonstimulants may be an appropriate alternative in cases in which co-occurring conditions might prevent the administration of stimulants.
Food insecurity may be linked to behavioral problems and poorer cognitive performance in children.
The high risk for several neuropsychiatric and developmental disorders supports more extended use of genetic testing in child and adolescent psychiatry.
Early preterm birth is associated with a higher level of ADHD symptoms in preschool children.
Investigators conducted a retrospective observational study to assess the impact of psychostimulant medication on BMI and height in a group of children and adolescents with ADHD.
Medication continuity in youth with ADHD is affected by several potentially modifiable factors that could be productive targets of intervention for pediatricians.
Exposure to hypertensive disorders of pregnancy may be associated with an increase in the risk for ASD and ADHD in offspring.
These findings offer preliminary evidence of the validity of the short UPPS-P-C to screen for impulsivity traits in both typically developing children and in those with ADHD.
While the authors discovered no "sensitive period," the number of stressful events was moderately associated with the severity of attention-deficit/hyperactivity disorder symptoms.
There are considerable gaps in knowledge relating to the effectiveness of nonpharmacologic treatments for ADHD in pediatric patients.
The results of the study point to effective alternatives to psychopharmacologic treatments with methylphenidate for patients who experience nonresponse, contraindications, or adverse events, or for patients who prefer nonpsychopharmacologic treatments.
Just as we need to be able to identify who is likely to benefit from treatment, we also need to be able to identify those who are most at risk of experiencing adverse events.
Antipsychotics have been shown to reduce tic severity, as has behavior therapy. However, the mechanisms behind the efficacy of behavior therapy have yet to be clarified by research.
These findings may raise new hypotheses for understanding the origins of ADHD, gender differences, and future targets in the prevention of ADHD.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Nomophobia: The Modern-Day Pathology
- Emerging Theories in the Pathophysiology of MDD: Could the Opioid System Be Involved?
- Combination Cognitive Behavioral Therapy With Fluoxetine Effective for Adolescent Depression
- Transdermal Nicotine Boosts Mood and Cognitive Function in Late-Life Depression
- Prazosin May Be Effective as Treatment for Alcohol Use Disorder
- Panel Recommends Earlier Body Weight Monitoring in Use of Mood Stabilizers
- Nondaily Cigarette Use Increasing Among Individuals With Mental Health, Substance Use Disorders
- Cesarean Delivery, Early Childhood Antibiotic Use Not Associated With Risk for ADHD
- Uncertainty as a Form of Violence: Current Immigration Policy and Crisis
- FDA Gets Tough on Juul, Other Electronic Cigarette Makers